{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T02:35:28Z","timestamp":1740105328786,"version":"3.37.3"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010229","name":"Natural Science Foundation of Tianjin Municipal Science and Technology Commission","doi-asserted-by":"publisher","award":["21JCYBJC00320"],"award-info":[{"award-number":["21JCYBJC00320"]}],"id":[{"id":"10.13039\/501100010229","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006606","name":"Natural Science Foundation of Tianjin Municipality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073341"],"award-info":[{"award-number":["82073341"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.bbrc.2024.151155","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T17:18:43Z","timestamp":1733505523000},"page":"151155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["PEG-modification enhances the targeted photothermal therapy of affibody-conjugated indocyanine green for precision cancer treatment"],"prefix":"10.1016","volume":"742","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6795-8545","authenticated-orcid":false,"given":"Yanting","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuerui","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7447-8750","authenticated-orcid":false,"given":"Hongru","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhangyong","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbrc.2024.151155_bib1","doi-asserted-by":"crossref","first-page":"8720","DOI":"10.1038\/s41598-018-26978-1","article-title":"Temperature-dependent cell death patterns induced by functionalized gold nanoparticle photothermal therapy in melanoma cells","volume":"8","author":"Zhang","year":"2018","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.bbrc.2024.151155_bib2","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41571-020-0410-2","article-title":"Clinical development and potential of photothermal and photodynamic therapies for cancer","volume":"17","author":"Li","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.bbrc.2024.151155_bib3","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1039\/C8CS00618K","article-title":"Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer","volume":"48","author":"Liu","year":"2019","journal-title":"Chem. Soc. Rev."},{"issue":"21","key":"10.1016\/j.bbrc.2024.151155_bib4","doi-asserted-by":"crossref","first-page":"14443","DOI":"10.1039\/D3RA02620E","article-title":"Nanomaterials for photothermal cancer therapy","volume":"13","author":"Duan","year":"2023","journal-title":"RSC Adv."},{"issue":"6","key":"10.1016\/j.bbrc.2024.151155_bib5","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41565-024-01618-0","article-title":"Photothermal therapy of tuberculosis using targeting pre-activated macrophage membrane-coated nanoparticles","volume":"19","author":"Li","year":"2024","journal-title":"Nat. Nanotechnol."},{"issue":"1","key":"10.1016\/j.bbrc.2024.151155_bib6","doi-asserted-by":"crossref","first-page":"6567","DOI":"10.1038\/s41467-023-42399-9","article-title":"NIR-dye bridged human serum albumin reassemblies for effective photothermal therapy of tumor","volume":"14","author":"Shi","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bbrc.2024.151155_bib7","doi-asserted-by":"crossref","first-page":"6905","DOI":"10.1038\/s41467-023-42740-2","article-title":"An autocatalytic multicomponent DNAzyme nanomachine for tumor-specific photothermal therapy sensitization in pancreatic cancer","volume":"14","author":"Yan","year":"2023","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.bbrc.2024.151155_bib8","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1208\/s12248-012-9339-4","article-title":"Challenges in development of nanoparticle-based therapeutics","volume":"14","author":"Desai","year":"2012","journal-title":"AAPS J."},{"issue":"12","key":"10.1016\/j.bbrc.2024.151155_bib9","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1093\/ajhp\/zxab048","article-title":"Tackling the challenges of nanomedicines: are we ready?","volume":"78","author":"Hertig","year":"2021","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.bbrc.2024.151155_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-642-41199-1_1","article-title":"Therapeutic potential of small molecules and engineered proteins","volume":"219","author":"Gurevich","year":"2014","journal-title":"Handb. Exp. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbrc.2024.151155_bib11","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1080\/10717544.2022.2120566","article-title":"Monoclonal antibody as a targeting mediator for nanoparticle targeted delivery system for lung cancer","volume":"29","author":"Wathoni","year":"2022","journal-title":"Drug Deliv."},{"issue":"5","key":"10.1016\/j.bbrc.2024.151155_bib12","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41423-020-0417-8","article-title":"Challenges and strategies for next-generation bispecific antibody-based antitumor therapeutics","volume":"17","author":"Li","year":"2020","journal-title":"Cell. Mol. Immunol."},{"issue":"4","key":"10.1016\/j.bbrc.2024.151155_bib13","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.apsb.2023.11.029","article-title":"Emerging non-antibody\u2012drug conjugates (non-ADCs) therapeutics of toxins for cancer treatment","volume":"14","author":"Xu","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.bbrc.2024.151155_bib14","doi-asserted-by":"crossref","first-page":"9765","DOI":"10.1038\/s41598-020-66646-x","article-title":"Highly reliable, targeted photothermal cancer therapy combined with thermal dosimetry using a near-infrared absorbent","volume":"10","author":"Nomura","year":"2020","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.bbrc.2024.151155_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202002504","article-title":"Solutions to the drawbacks of photothermal and photodynamic cancer therapy","volume":"8","author":"Deng","year":"2021","journal-title":"Adv. Sci."},{"issue":"8","key":"10.1016\/j.bbrc.2024.151155_bib16","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.tibtech.2017.04.007","article-title":"Affibody molecules in biotechnological and medical applications","volume":"35","author":"Stahl","year":"2017","journal-title":"Trends Biotechnol."},{"issue":"3","key":"10.1016\/j.bbrc.2024.151155_bib17","doi-asserted-by":"crossref","first-page":"e306","DOI":"10.1038\/emm.2017.35","article-title":"Affibody molecules as engineered protein drugs","volume":"49","author":"Frejd","year":"2017","journal-title":"Exp. Mol. Med."},{"issue":"8","key":"10.1016\/j.bbrc.2024.151155_bib18","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1158\/0008-5472.CAN-05-3521","article-title":"Tumor imaging using a picomolar affinity HER2 binding affibody molecule","volume":"66","author":"Orlova","year":"2006","journal-title":"Cancer Res."},{"issue":"Pt A","key":"10.1016\/j.bbrc.2024.151155_bib19","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.ijbiomac.2017.09.059","article-title":"Affibody molecules for molecular imaging and targeted drug delivery in the management of breast cancer","volume":"107","author":"De","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbrc.2024.151155_bib20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-1-0716-3279-6_7","article-title":"Bacterial cell display for selection of affibody molecules","volume":"2681","author":"Dahlsson","year":"2023","journal-title":"Methods Mol. Biol."},{"issue":"10","key":"10.1016\/j.bbrc.2024.151155_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24108680","article-title":"Recent advances on affibody- and DARPin-conjugated nanomaterials in cancer therapy","volume":"24","author":"Gabriele","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2024.151155_bib22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/978-1-61779-921-1_7","article-title":"Engineering of affibody molecules for therapy and diagnostics","volume":"899","author":"Feldwisch","year":"2012","journal-title":"Methods Mol. Biol."},{"issue":"12","key":"10.1016\/j.bbrc.2024.151155_bib23","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.1158\/1078-0432.CCR-07-4076","article-title":"Affibody molecules for in vivo characterization of HER2-positive tumors by near-infrared imaging","volume":"14","author":"Lee","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.bbrc.2024.151155_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18061332","article-title":"The application of heptamethine cyanine dye DZ-1 and indocyanine green for imaging and targeting in xenograft models of hepatocellular carcinoma","volume":"18","author":"Zhang","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2024.151155_bib25","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.2147\/IJN.S295234","article-title":"Interventional NIR fluorescence imaging of cancer: review on next generation of dye-loaded protein-based nanoparticles for real-time feedback during cancer surgery","volume":"16","author":"Borlan","year":"2021","journal-title":"Int. J. Nanomed."},{"issue":"8","key":"10.1016\/j.bbrc.2024.151155_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/biom12081044","article-title":"Recent progress in second near-infrared (NIR-II) fluorescence imaging in cancer","volume":"12","author":"Wang","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbrc.2024.151155_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121609","article-title":"Her3-specific affibody mediated tumor targeting delivery of ICG enhanced the photothermal therapy against Her3-positive tumors","volume":"617","author":"Liu","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.bbrc.2024.151155_bib28","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1186\/s12951-023-02133-5","article-title":"Targeted delivery of organic small-molecule photothermal materials with engineered extracellular vesicles for imaging-guided tumor photothermal therapy","volume":"21","author":"Dong","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bbrc.2024.151155_bib29","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jconrel.2020.06.032","article-title":"Photothermal therapy","volume":"325","author":"Zhi","year":"2020","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bbrc.2024.151155_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121609","article-title":"Her3-specific affibody mediated tumor targeting delivery of ICG enhanced the photothermal therapy against Her3-positive tumors","volume":"617","author":"Liu","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.bbrc.2024.151155_bib31","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1021\/acs.molpharmaceut.2c00708","article-title":"ICG-dimeric Her2-specific affibody conjugates for tumor imaging and photothermal therapy for Her2-positive tumors","volume":"20","author":"Jia","year":"2023","journal-title":"Mol. Pharm."},{"issue":"3","key":"10.1016\/j.bbrc.2024.151155_bib32","doi-asserted-by":"crossref","first-page":"e306","DOI":"10.1038\/emm.2017.35","article-title":"Affibody molecules as engineered protein drugs","volume":"49","author":"Frejd","year":"2017","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bbrc.2024.151155_bib33","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.isci.2019.11.022","article-title":"Utilizing polymer micelle to control dye J-aggregation and enhance its theranostic capability","volume":"22","author":"Shao","year":"2019","journal-title":"iScience"},{"issue":"10","key":"10.1016\/j.bbrc.2024.151155_bib34","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1002\/jps.10470","article-title":"Degradation kinetics of indocyanine green in aqueous solution","volume":"92","author":"Saxena","year":"2003","journal-title":"J. Pharmaceut. Sci."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X24016917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X24016917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T08:57:47Z","timestamp":1737622667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X24016917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":34,"alternative-id":["S0006291X24016917"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.151155","relation":{},"ISSN":["0006-291X"],"issn-type":[{"type":"print","value":"0006-291X"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PEG-modification enhances the targeted photothermal therapy of affibody-conjugated indocyanine green for precision cancer treatment","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.151155","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"151155"}}